HomeIRLAB-A • STO
add
IRLAB Therapeutics AB
Previous close
kr 5.22
Day range
kr 5.02 - kr 5.30
Year range
kr 4.25 - kr 20.20
Market cap
264.12M SEK
Avg Volume
86.63K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
In the news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 42.82M | 3,692.28% |
Operating expense | 7.63M | -65.17% |
Net income | -5.40M | 84.58% |
Net profit margin | -12.60 | -100.43% |
Earnings per share | — | — |
EBITDA | -1.88M | 95.78% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 66.92M | -39.88% |
Total assets | 136.21M | -23.10% |
Total liabilities | 103.58M | 68.81% |
Total equity | 32.64M | — |
Shares outstanding | 51.87M | — |
Price to book | 8.29 | — |
Return on assets | -5.06% | — |
Return on capital | -7.84% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -5.40M | 84.58% |
Cash from operations | -22.61M | 33.24% |
Cash from investing | — | — |
Cash from financing | -860.00K | -103.26% |
Net change in cash | -23.47M | -212.68% |
Free cash flow | -21.93M | 19.95% |
About
Founded
2013
Website
Employees
31
